|
Volumn 49 Suppl 1, Issue , 2009, Pages 95-101
|
The treatment of hypertension with telmisartan in the sphere of circadian rhythm in metabolic syndrome in the elderly.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
TELMISARTAN;
AGE;
AGED;
ARTICLE;
BLOOD PRESSURE;
CIRCADIAN RHYTHM;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FOLLOW UP;
HUMAN;
HYPERTENSION;
METABOLIC SYNDROME X;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
BENZIMIDAZOLES;
BENZOATES;
BLOOD PRESSURE;
CIRCADIAN RHYTHM;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION;
METABOLIC SYNDROME X;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 75549087455
PISSN: None
EISSN: 18726976
Source Type: Journal
DOI: 10.1016/j.archger.2009.09.017 Document Type: Article |
Times cited : (8)
|
References (0)
|